Episode summary
The physiology behind blood flow restriction training, what each of its pillars can achieve, how it compares with low-load and high-load training, and what the clinical trials in ACL rehabilitation show.
The speaker explains that Henneman's size principle largely holds during BFR training. Venous occlusion lowers oxygen supply, brings on earlier anaerobic glycolysis and metabolite accumulation, and forces type 2 fibers to be recruited, which stimulates the mTOR pathway. The cost is discomfort and ischemic muscle pain.
Passive BFR may limit losses but probably adds no muscle mass or strength. Aerobic BFR can improve mass and strength in deconditioned people, aerobic capacity, pain and function. Resistance training with BFR gives the broadest effects, including on hypertrophy, strength, pain and bone. BFR beats low-load training alone and matches high-load training for muscle mass, but high loads may still give more strength, which is why he calls BFR a bridge, though recent work questions this.
Of more than 70 ACL papers, only 13 are clinical trials. He reviews strength gains in chronic postoperative atrophy, safe use in 12- to 18-year-olds, bone mass, prehabilitation, and a placebo-controlled trial with 48 athletes, concluding that heterogeneous protocols call for a criteria-based progression.